// immunotherapies

Our Partnerships

Partnering is a key component of our corporate strategy. eTheRNA is exploring innovative ideas – at all stages of development.

eTheRNA focuses on maximizing the value of its proprietary TriMix technology via three routes:

Technology Partnering
eTheRNA intends to build high-value strategic collaborations for exploring the benefits of the TriMix technology in various disease areas.





Product
Partnering
eTheRNA seeks collaborative partnerships with pharma companies that enable us to develop - and ultimately also to commercialize - differentiated TriMix-based immunotherapies on either a risk-sharing or out-licensing basis.


mRNA Production Partnering
eTheRNA operates a cGMP accredited mRNA production facility in Niel, Belgium and currently focusses on producing mRNA-constructs exclusively for its own development plans. However as the clinical development program advances, the Company has the option to expand capacity and explore strategic partnerships.

Galileilaan 19, 2845 Niel, Belgium

Our Address

Our Mailbox

+32 3 369 17 40

Our Phone

© 2020 Etherna | Studio Hanswijk